Over- and Under-Treatment of Stage II and III Colorectal Cancer in the Adjuvant Setting

Stacey A. Cohen, MD, and Daniel H. Ahn, DO, describe the challenges of deciding which patients with colorectal cancer should receive adjuvant therapy, and the risk of over- and under-treatment in later stages.

Related Videos
Experts on RCC
Experts on RCC
Experts on GVHD with a patient
Experts on GVHD with a patient
Experts on RCC
Experts on RCC
Experts on RCC
Experts on RCC
Related Content